Detailed information for compound 1540618

Basic information

Technical information
  • TDR Targets ID: 1540618
  • Name: 2-(2-hydroxyethyl)-1-methyl-5,6,7,8-tetrahydr opyrazolo[1,2-a]pyridazin-3-one
  • MW: 196.246 | Formula: C10H16N2O2
  • H donors: 1 H acceptors: 2 LogP: 0.5 Rotable bonds: 2
    Rule of 5 violations (Lipinski): 1
  • SMILES: OCCc1c(C)n2n(c1=O)CCCC2
  • InChi: 1S/C10H16N2O2/c1-8-9(4-7-13)10(14)12-6-3-2-5-11(8)12/h13H,2-7H2,1H3
  • InChiKey: ORJKQXRTOUWWQR-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • 18159-93-8
  • 2-(2-Hydroxyethyl)-3-methyl-5,6,7,8-tetrahydro-1H-pyrazolo[1,2-a]pyridazin-1-one
  • AIDS-126647
  • AIDS126647
  • NSC120312
  • 2-(2-Hydroxyethyl)-3-methyl-5,6,7,8-tetrahydro-1H-pyrazolo(1,2-a)pyridazin-1-one
  • NSC 120312

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens SMAD family member 2 Starlite/ChEMBL No references
Homo sapiens ataxin 2 Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Loa Loa (eye worm) transcription factor SMAD2 Get druggable targets OG5_131716 All targets in OG5_131716
Loa Loa (eye worm) MH2 domain-containing protein Get druggable targets OG5_131716 All targets in OG5_131716
Brugia malayi MH2 domain containing protein Get druggable targets OG5_131716 All targets in OG5_131716
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Brugia malayi MH2 domain containing protein SMAD family member 2 467 aa 405 aa 31.6 %
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Plasmodium falciparum ataxin-2 like protein, putative 0.003 0.0837 1
Echinococcus multilocularis ornithine aminotransferase 0.0021 0.0114 0.5
Loa Loa (eye worm) transcription factor SMAD2 0.0144 0.9656 1
Mycobacterium ulcerans hypothetical protein 0.0149 1 1
Schistosoma mansoni ornithine--oxo-acid transaminase 0.0021 0.0114 0.5
Brugia malayi 4-aminobutyrate aminotransferase, mitochondrial precursor 0.0021 0.0114 0.0119
Mycobacterium ulcerans adenosylmethionine-8-amino-7-oxononanoate aminotransferase 0.0149 1 1
Echinococcus granulosus ornithine aminotransferase 0.0021 0.0114 0.5
Trypanosoma brucei PAB1-binding protein , putative 0.003 0.0837 0.5
Brugia malayi MH2 domain containing protein 0.0144 0.9656 1
Leishmania major hypothetical protein, conserved 0.003 0.0837 0.5
Plasmodium falciparum ataxin-2 like protein, putative 0.003 0.0837 1
Trypanosoma cruzi PAB1-binding protein , putative 0.003 0.0837 0.5
Trichomonas vaginalis acetylornithine aminotransferase, putative 0.0149 1 0.5
Brugia malayi hypothetical protein 0.003 0.0837 0.0866
Echinococcus granulosus Aminotransferase class III 0.0021 0.0114 0.5
Loa Loa (eye worm) MH2 domain-containing protein 0.0144 0.9656 1
Chlamydia trachomatis glutamate-1-semialdehyde-2,1-aminomutase 0.0021 0.0114 0.5
Trypanosoma cruzi PAB1-binding protein , putative 0.003 0.0837 0.5
Wolbachia endosymbiont of Brugia malayi acetylornithine transaminase protein 0.0021 0.0114 0.5
Mycobacterium tuberculosis Adenosylmethionine-8-amino-7-oxononanoate aminotransferase BioA 0.0149 1 1
Echinococcus multilocularis Aminotransferase class III 0.0021 0.0114 0.5
Toxoplasma gondii LsmAD domain-containing protein 0.003 0.0837 1
Mycobacterium tuberculosis Probable aminotransferase 0.0149 1 1
Echinococcus multilocularis ornithine aminotransferase 0.0021 0.0114 0.5
Plasmodium vivax ataxin-2 like protein, putative 0.003 0.0837 1

Activities

Activity type Activity value Assay description Source Reference
Potency (functional) 3.1623 uM PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] ChEMBL. No reference
Potency (functional) 6.7016 uM PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.